Cargando…

CMTM5-v1 inhibits cell proliferation and migration by downregulating oncogenic EGFR signaling in prostate cancer cells

Anomalous epidermal growth factor receptor (EGFR) signaling plays an important role in the progression of prostate cancer (PCa) and the transformation to castration-resistant PCa (CRPC). A novel tumor suppressor CKLF-like MARVEL transmembrane domain-containing member 5(CMTM5) has a MARVEL domain and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Yeqing, Sheng, Zhengzuo, Liu, Zhenhua, Zhang, Xiaowei, Xiao, Yunbei, Xie, Jing, Zhang, Yixiang, Xu, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171480/ https://www.ncbi.nlm.nih.gov/pubmed/32328181 http://dx.doi.org/10.7150/jca.42314

Ejemplares similares

AB179. CMTM3 is reduced in prostate cancer and inhibits migration, invasion and growth of LNCaP cells
por: Hu, Fengzhan, et al.
Publicado: (2015)

Involvement of cancer-derived IgG in the proliferation, migration and invasion of bladder cancer cells
por: Sheng, Zhengzuo, et al.
Publicado: (2016)

CMTM5 inhibits renal cancer cell growth through inducing cell-cycle arrest and apoptosis
por: Cai, Bing, et al.
Publicado: (2017)

Effects of oleic acid on cell proliferation through an integrin-linked kinase signaling pathway in 786-O renal cell carcinoma cells
por: LIU, ZHENHUA, et al.
Publicado: (2013)

IgG is involved in the migration and invasion of clear cell renal cell carcinoma
por: Sheng, Zhengzuo, et al.
Publicado: (2016)

CMTM3 Overexpression Predicts Poor Survival and Promotes Proliferation and Migration in Pancreatic Cancer
por: Zhou, Zixuan, et al.
Publicado: (2021)

CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma
por: Li, Ting, et al.
Publicado: (2015)

CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway
por: Li, Linjin, et al.
Publicado: (2022)

CMTM3 inhibits cell migration and invasion and correlates with favorable prognosis in gastric cancer
por: Su, Yu, et al.
Publicado: (2014)

CMTM6 and CMTM4 as two novel regulators of PD-L1 modulate the tumor microenvironment
por: Zhang, Tong, et al.
Publicado: (2022)

Identification of CMTM6 and CMTM4 as PD-L1 protein regulators
por: Mezzadra, Riccardo, et al.
Publicado: (2017)

CMTM6 promotes migration, invasion, and EMT by interacting with and stabilizing vimentin in hepatocellular carcinoma cells
por: Huang, Xiaoting, et al.
Publicado: (2021)

CMTM6 and CMTM7: New leads for PD‐L1 regulation in breast cancer cells undergoing EMT
por: Xiao, Malina, et al.
Publicado: (2022)

Exosomal miR-224-5p from Colorectal Cancer Cells Promotes Malignant Transformation of Human Normal Colon Epithelial Cells by Promoting Cell Proliferation through Downregulation of CMTM4
por: Wu, Feng, et al.
Publicado: (2022)

Expressions of ZNF436, β-catenin, EGFR, and CMTM5 in breast cancer and their clinical significances
por: Chen, Zhi, et al.
Publicado: (2021)

Overexpression of a novel candidate oncogene KIF14 correlates with tumor progression and poor prognosis in prostate cancer
por: Zhang, Yixiang, et al.
Publicado: (2017)

CKLF-Like MARVEL Transmembrane Domain-Containing Member 3 (CMTM3) Inhibits the Proliferation and Tumorigenisis in Hepatocellular Carcinoma Cells
por: Li, Wujun, et al.
Publicado: (2017)

Knockdown of MAPK14 inhibits the proliferation and migration of clear cell renal cell carcinoma by downregulating the expression of CDC25B
por: Liu, Junlong, et al.
Publicado: (2019)

CDCA2 Inhibits Apoptosis and Promotes Cell Proliferation in Prostate Cancer and Is Directly Regulated by HIF-1α Pathway
por: Zhang, Yixiang, et al.
Publicado: (2020)

Analysis of CMTM6 and CMTM4 expression as potential regulators of the PD-L1 protein and its association with prognosis in glioma cancer
por: Xue, Hui, et al.
Publicado: (2022)

Downregulation of CDKL1 suppresses neuroblastoma cell proliferation, migration and invasion
por: Li, Weiyi, et al.
Publicado: (2019)

Expression and clinical significance of CMTM1 in hepatocellular carcinoma
por: Song, Xin, et al.
Publicado: (2021)

MicroRNA-205 inhibits renal cells apoptosis via targeting CMTM4
por: Zhang, Hongxia, et al.
Publicado: (2015)

CMTM7 knockdown increases tumorigenicity of human non-small cell lung cancer cells and EGFR-AKT signaling by reducing Rab5 activation
por: Liu, Baocai, et al.
Publicado: (2015)

Expression Analysis of Canine CMTM6 and CMTM4 as Potential Regulators of the PD-L1 Protein in Canine Cancers
por: Takeuchi, Hiroto, et al.
Publicado: (2020)

Schwann-cell-derived CMTM6 restricts radial axonal growth
por: Elazar, Nimrod, et al.
Publicado: (2020)

METTL13 is downregulated in bladder carcinoma and suppresses cell proliferation, migration and invasion
por: Zhang, Zhe, et al.
Publicado: (2016)

Clinical significance of CMTM4 expression in hepatocellular carcinoma
por: Bei, Chunhua, et al.
Publicado: (2017)

Downregulation of PITX2 inhibits the proliferation and migration of liver cancer cells and induces cell apoptosis
por: Tuerxun, Kebinuer, et al.
Publicado: (2021)

Downregulation of SUMO2 inhibits hepatocellular carcinoma cell proliferation, migration and invasion
por: Chen, Jintu, et al.
Publicado: (2021)

Epithelial to Mesenchymal Transition Regulates Surface PD-L1 via CMTM6 and CMTM7 Induction in Breast Cancer
por: Xiao, Malina, et al.
Publicado: (2021)

CMTM3 suppresses chordoma progress through EGFR/STAT3 regulated EMT and TP53 signaling pathway
por: Yuan, Wanqiong, et al.
Publicado: (2021)

Current Opinions on the Relationship Between CMTM Family and Hepatocellular Carcinoma
por: Pei, Yulin, et al.
Publicado: (2023)

CMTM5 is downregulated and suppresses tumour growth in hepatocellular carcinoma through regulating PI3K-AKT signalling
por: Xu, Gang, et al.
Publicado: (2017)

miR-sc8 Inhibits Schwann Cell Proliferation and Migration by Targeting Egfr
por: Gu, Yun, et al.
Publicado: (2015)

Identification of CMTM7 as a Transmembrane Linker of BLNK and the B-Cell Receptor
por: Miyazaki, Atsuko, et al.
Publicado: (2012)

Prognostic significance and immune characteristics of CMTM4 in hepatocellular carcinoma
por: Tan, Shengkui, et al.
Publicado: (2022)

Oncogenes and cell proliferation
Publicado: (1992)

CMTM Family and Gastrointestinal Tract Cancers: A Comprehensive Review
por: Li, Jie, et al.
Publicado: (2022)

Expression of CMTM4 shows clinical significance in lung cancer
por: Zhu, Xiaonian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i2p4o3hqm3sg5thms35elvc9c6